Advertisement
Canada markets close in 18 minutes
  • S&P/TSX

    21,969.67
    +84.29 (+0.39%)
     
  • S&P 500

    5,105.75
    +57.33 (+1.14%)
     
  • DOW

    38,270.33
    +184.53 (+0.48%)
     
  • CAD/USD

    0.7319
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    83.63
    +0.06 (+0.07%)
     
  • Bitcoin CAD

    87,256.37
    -994.56 (-1.13%)
     
  • CMC Crypto 200

    1,331.56
    -64.98 (-4.49%)
     
  • GOLD FUTURES

    2,349.20
    +6.70 (+0.29%)
     
  • RUSSELL 2000

    2,002.43
    +21.32 (+1.08%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,947.61
    +335.85 (+2.15%)
     
  • VOLATILITY

    14.93
    -0.44 (-2.86%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     

Stocks in play: BELLUS Health Inc.

Has completed patient enrollment for the RELIEF trial, its dose-escalation, placebo-controlled Phase 2 trial of BLU-5937 in patients with refractory chronic cough. BELLUS Health Inc. shares T.BLU are trading up $1.12 at $10.54.

Read: